A Phase-Ii Study of Combination of Pegylated Interferon Alfa-2a and Capecitabine in Locally Advanced or Metastatic Renal Cell Cancer

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-009-1134-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC